ADULT
Clinical trials for ADULT explained in plain language.
Never miss a new study
Get alerted when new ADULT trials appear
Sign up with your email to follow new studies for ADULT, keep track of the ones that matter, and come back to a personal dashboard instead of checking manually.
By submitting, you agree to our Terms of use
-
Experimental immune cell therapy targets advanced cancers
Disease control TerminatedThis early-phase study tested an experimental treatment called GT101 for people with advanced solid tumors that had spread or returned. The approach involved collecting the patient's own immune cells from the tumor, growing them in a lab, and giving them back along with chemother…
Matched conditions: ADULT
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 17, 2026 00:43 UTC
-
Experimental cell therapy for advanced gynecological cancers shows early safety data
Disease control TerminatedThis early study tested a new treatment called GT201 for people with advanced gynecological tumors, including cervical cancer. The treatment uses a patient's own immune cells (tumor-infiltrating lymphocytes) to fight the cancer. The study was very small with only 4 participants a…
Matched conditions: ADULT
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 13, 2026 16:02 UTC
-
Cancer-Fighting immune cell therapy trial ends early
Disease control TerminatedThis trial tested a treatment that uses a patient's own immune cells (tumor-infiltrating lymphocytes) to attack advanced solid tumors. The goal was to see if it was safe and tolerable. Only 2 people took part before the study was stopped early.
Matched conditions: ADULT
Phase: EARLY_PHASE1 • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 13, 2026 16:00 UTC
-
Personalized cell therapy for advanced lung cancer shows early promise
Disease control TerminatedThis study tested a treatment called GT201, which uses immune cells taken from a patient's own tumor to attack cancer. It was designed for adults with advanced lung cancer who had already tried other treatments. The study was stopped early after enrolling only 2 people, so result…
Matched conditions: ADULT
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 13, 2026 15:58 UTC
-
Lung cancer cell therapy trial halted after just 2 patients
Disease control TerminatedThis study tested a new treatment for advanced non-small cell lung cancer using a patient's own immune cells (TILs) combined with an immunotherapy drug. The goal was to see if the combination was safe and tolerable. However, the trial was terminated early and only enrolled 2 peop…
Matched conditions: ADULT
Phase: NA • Sponsor: Grit Biotechnology • Aim: Disease control
Last updated May 08, 2026 12:00 UTC
-
Sticker shock: simple reminder aims to cut unnecessary IV antibiotic use
Knowledge-focused TerminatedThis study tested whether placing a sticker reminder on patient charts would encourage doctors to switch from intravenous (IV) to oral fluoroquinolone antibiotics sooner. The trial included 168 adults with infections who were receiving IV fluoroquinolones. The study was terminate…
Matched conditions: ADULT
Phase: NA • Sponsor: Mahidol University • Aim: Knowledge-focused
Last updated May 15, 2026 11:53 UTC